Diabetes to weight loss to heart defence: Ozempic and Mounjaro protect against strokes and heart attacks, finds study
New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. A real-world study found these medications substantially reduced the risk of strokes and heart attacks in type 2 diabetes patients. These findings suggest a potential turning point in diabetes care, highlighting the drugs' protective effects on the heart.
New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. A real-world study found these medications substantially reduced the risk of strokes and heart attacks in type 2 diabetes patients. These findings suggest a potential turning point in diabetes care, highlighting the drugs' protective effects on the heart.
